N5408

Monoclonal Anti-Nerve Growth Factor Receptor (NGFR p75) antibody produced in mouse

clone ME20.4, ascites fluid

• Synonym(s): Anti-NGFR p75
• UNSPSC Code: 51111800
• NACRES: NA.41
• MDL number: MFCD00282384
• Conjugate: unconjugated
• Clone: ME20.4, monoclonal
• Application: ARR, ELISA (i), FACS, IHC (f), IHC (p), IP, Neutral, RIA, WB
• Citations: 20

Properties

• biological source: mouse
• Quality Segment: 200
• conjugate: unconjugated
• antibody form: ascites fluid
• antibody product type: primary antibodies
• clone: ME20.4, monoclonal
• mol wt: antigen 75 kDa
• contains: 15 mM sodium azide
• species reactivity: racoon, monkey, pig, human, feline
• should not react with: mouse, chicken, rat
• technique(s): flow cytometry: suitable, immunohistochemistry (formalin-fixed, paraffin-embedded sections): 1:1,000 using human tongue, immunohistochemistry (frozen sections): suitable, immunoprecipitation (IP): suitable, indirect ELISA: suitable, microarray: suitable, neutralization: suitable, radioimmunoassay: suitable, western blot: suitable
• isotype: IgG1
• UniProt accession no.: P08138
• shipped in: dry ice
• storage temp.: −20°C
• target post-translational modification: unmodified
• Gene Information: human ... NGFR(4804)

Description

General description

Monoclonal Anti-Nerve Growth Factor Receptor (NGFR p75) (mouse IgG1 isotype) is derived from the ME20.4 hybridoma produced by the fusion of mouse myeloma cells and splenocytes from a BALB/c mouse immunized with a human melanoma cell line WM245. The human NGFR p75 has a hydrophobic signal sequence, a single N-linked glycosylation site, four cysteine-rich repeat units of approximately 40 amino acids in the extracellular domain, a serine- and threonine-rich region which might be O-linked glycosylated, a single transmembrane domain, and a 155-amino acid cytoplasmic domain.

Recognizes the low affinity human NGFR p75 (also known as gp75^NGFR , p75^NGFR and p75^NTR). The epitope recognized by the antibody exists within the third or fourth cysteine-rich repeats of the NGFR molecule.

Immunogen

human melanoma cell line WM245.

Application

Monoclonal Anti-Nerve Growth Factor Receptor (NGFR p75) antibody produced in mouse has been used in immunoblotting. to added in CB.

Monoclonal Anti-Nerve Growth Factor Receptor (NGFR p75) may be used:

• for enzyme linked immune sorbent assay (ELISA)
• immunoprecipitation, immunoblotting and immunohistochemistry
• for immunocytochemistry (acetone- or formalin-fixed, Bouin′s solution - or formalin- fixed paraffin-embedded)
• for electron- microscopy radioimmunoassay (RIA) (Kd of 7x10-10 M)
• flow cytometry
• for the inhibition of binding of NGF to the receptor
• for rossette assay
• as a cholinergic immunotoxin

Biochem/physiol Actions

Monoclonal Anti-Nerve Growth Factor Receptor (NGFR p75) recognizes the low affinity NGFR p75 of human origin (75 kDa), also known as gp75^NGFR, p75^NGFR and p75^NTR .The epitope recognized by the antibody is located within the third or fourth cysteine-rich repeats of the NGFR molecule. Cross-reactivity has been observed with human, monkey (marmoset), pig, cat and raccoon , but not with rat, chicken or mouse NGFR.

Nerve Growth Factor Receptor (NGFR) p75 enhances the NGF binding affinity of the proto-oncogene product p140trk and also may modulate the kinase activity of p140trk and play a role in signal transduction. Specifically, neurotrophin binding to NGFR p75 stimulates generation of ceramide, activation and translocation of nuclear factor- κ (NF-κB) to the nucleus, and enhancement of Jun kinase (JNK) activity.

Neurotrophins (NT) are growth factors that are essential for the development and maintenance of the nervous system. One of the receptors that mediate the effects of NTs is the Nerve Growth Factor Receptor/TNFRSF16 (p75NGFR, p75NTR). NGFR mediates the effects of NGF that are important in the survival and differentiation of neurons and neural crest-derived cells, during embryonic and early postnatal development. Expression of NGFR has been associated with favorable prognosis and survival in breast and pancreatic cancers.

Physical form

The product is supplied as ascites fluid with 15 mM sodium azide as a preservative.

Preparation Note

For continuous use, store at 2-8 °C for up to one month. For extended storage, freeze in working aliquots. Repeated freezing and thawing is not recommended. Storage in "frost-free" freezers is not recommended. If slight turbidity occurs upon prolonged storage, clarify the solution by centrifugation before use. Working dilution samples should be discarded if not used within 12 hours.

Disclaimer

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

Safety Information

• Storage Class: 10 - Combustible liquids
• wgk: nwg
• flash_point_f: Not applicable
• flash_point_c: Not applicable